Publications by authors named "Haoyi Zhou"

To tackle the clinical challenge of noninvasively assessing immunotherapy efficacy in patients, here we used positron emission tomography (PET) with Ga-grazytracer, which targets granzyme B, a crucial effector molecule secreted by activated CD8 T cells. In this phase 1/2 clinical trial (NCT05000372) involving a diverse cohort of 24 patients with solid tumors and lymphomas who received immunotherapies, including immune checkpoint inhibitors (either alone or with chemotherapies) and chimeric antigen receptor-T cell therapy, we examined the in vivo behaviors of Ga-grazytracer. Primary endpoints were safety, biodistribution, granzyme B specificity, and the predictive utility of Ga-grazytracer, while secondary endpoint was the relationship between Ga-grazytracer uptake and tumor immune phenotype.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the use of immunohistochemical staining of PD-L1 in tumor biopsies to identify patients who could benefit from anti-PD-1 therapy, while noting the varied expression of PD-L1 in different cell types within tumors.
  • Researchers developed polymer-based lysosome-targeting chimeras (LYTACs) to selectively degrade PD-L1 on liver cancer cells without affecting host cells, using advanced PET imaging to track this process.
  • Findings indicate that PD-L1 expression on host cells is crucial for the effectiveness of anti-PD-1 therapy in liver cancer, suggesting that this novel LYTAC approach could improve our understanding of protein functions in various cell types in living subjects.
View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint blockade (ICB) is a type of cancer therapy that works well for some patients, but not everyone gets the same benefits.
  • Researchers wanted to find ways to predict how well a tumor would respond to this therapy, using tests on mice.
  • They discovered that a protein called galectin-1 (Gal-1) can help determine if the therapy will work, and they created a special imaging tool to see if Gal-1 was affecting the tumor before treatment starts.
View Article and Find Full Text PDF

Introduction: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea (OSA) are prevalent respiratory diseases in China and impose significant burdens on the healthcare system. Moreover, the co-occurrence of COPD and OSA exacerbates clinical outcomes significantly. However, comprehensive epidemiological investigations in China remain scarce, and the defining characteristics of the population affected by COPD and OSA, alongside their intrinsic relationship, remain ambiguous.

View Article and Find Full Text PDF
Article Synopsis
  • Radiotherapy can stimulate a broader immune response that helps attack tumors not directly targeted by the treatment, known as the abscopal effect, with ICAM-1 being a crucial player in this process.
  • This study explores the role of ICAM-1 in activating and aiding CD8 T cells' function during immunotherapy combined with radiotherapy, using noninvasive imaging techniques to assess CD8 T cell activity.
  • The research identified a drug, VS-6063, which enhances the ability of CD8 T cells to fight tumors by improving their movement into tumors, and emphasizes the potential of imaging ICAM-1 to guide effective combination therapies in cancer treatment.
View Article and Find Full Text PDF

Lymph node metastasis examined by the resected lymph nodes is considered one of the most important prognostic factors for colorectal cancer (CRC). However, it requires careful and comprehensive inspection by expert pathologists. To relieve the pathologists' burden and speed up the diagnostic process, in this paper, we develop a deep learning system with the binary positive/negative labels of the lymph nodes to solve the CRC lymph node classification task.

View Article and Find Full Text PDF

Accurately identifying patients who respond to immunotherapy remains clinically challenging. A noninvasive method that can longitudinally capture information about immune cell function and assist in the early assessment of tumor responses is highly desirable for precision immunotherapy. Here, we show that PET imaging using a granzyme B-targeted radiotracer named 68Ga-grazytracer, could noninvasively and effectively predict tumor responses to immune checkpoint inhibitors and adoptive T cell transfer therapy in multiple tumor models.

View Article and Find Full Text PDF

A novel method for the metal-free synthesis of amides from thioamides based on visible-light photoredox catalysis and in an air atmosphere is reported. Natural pigment chlorophyll is used as a photosensitizer to generate singlet molecular oxygen O, which is involved in the aerobic desulfurization of thioamides. The protocol provides amides in good yields at room temperature under mild conditions.

View Article and Find Full Text PDF

Purpose: Hypoxia is a hallmark of solid tumors that is related to radiotherapy resistance. As galectin members, such as galectin-1 and galectin-3, are associated with tumor hypoxia, herein we aimed to investigate whether positron emission tomography (PET) imaging of galectin expression can be employed to effectively pinpoint tumor hypoxia, and to predict radiotherapy resistance.

Methods: We synthesized a galectin-targeting radiotracer, designated Ga-galectracer, by radiolabeling a thiodigalactoside derivative.

View Article and Find Full Text PDF

Compelling evidence indicates that radiotherapy (RT) has a systemic inhibitory effect on nonirradiated lesions (abscopal effect) in addition to the ablation of irradiated tumors. However, this effect occurs only in rare circumstances in clinical practice, and mechanisms underlying the abscopal effect of RT are neither fully understood nor therapeutically utilized. Here we identified that intercellular adhesion molecule-1 (ICAM-1), an inducible glycoprotein of the immunoglobulin superfamily, is up-regulated in nonirradiated tumors responsive to RT.

View Article and Find Full Text PDF